PM&R最新文献

{"title":"A novel (seeding) technique for ultrasound-guided botulinum toxin injections.","authors":"Berkay Yalçınkaya, Ahmet Furkan Çolak, Murat Kara, Levent Özçakar","doi":"10.1002/pmrj.13357","DOIUrl":"10.1002/pmrj.13357","url":null,"abstract":"","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":"730-732"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143701314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Academy News - May 2025 PM&R.","authors":"","doi":"10.1002/pmrj.13442","DOIUrl":"https://doi.org/10.1002/pmrj.13442","url":null,"abstract":"","PeriodicalId":20354,"journal":{"name":"PM&R","volume":"17 6","pages":"734-735"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The healing role of music and arts in long COVID: A patient perspective.","authors":"Janna L Friedly, Joshua Roman, Jenny Long, Mehr Grewal, Anita Chopra, Jessica Bender, Nicole Gentile, Lindsey M Knowles, Tracy Herring, Kristen O'Loughlin, Nova Rivera","doi":"10.1002/pmrj.13430","DOIUrl":"10.1002/pmrj.13430","url":null,"abstract":"","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":"709-715"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of function-limiting late effects in survivors of head and neck cancer.","authors":"Yu Hui Won, Michael D Stubblefield","doi":"10.1002/pmrj.13340","DOIUrl":"10.1002/pmrj.13340","url":null,"abstract":"<p><strong>Background: </strong>Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long-term and late effects that can adversely affect their function and quality of life.</p><p><strong>Objective: </strong>To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC.</p><p><strong>Design: </strong>Retrospective cohort analysis.</p><p><strong>Setting: </strong>Outpatient cancer rehabilitation clinic at a physical medicine and rehabilitation hospital that includes a freestanding inpatient rehabilitation unit along with an outpatient clinic.</p><p><strong>Participants: </strong>One hundred thirty survivors of HNC who sought specialized cancer rehabilitation services to address complex functional impairments.</p><p><strong>Interventions: </strong>Not applicable.</p><p><strong>Main outcome measures: </strong>Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC.</p><p><strong>Results: </strong>The majority underwent surgery (53.8%), chemotherapy (22.3%), and radiation therapy (93.8%) as part of their treatment. Neuromuscular complications such as myelopathy (45.4%), radiculoplexopathy (58.5%), mononeuropathy (84.6%), and myopathy (57.7%) were prevalent. Musculoskeletal impairments included dysphagia (92.3%), dysarthria (60.8%), trismus (40.8%), cervical dystonia (47.7%), and shoulder dysfunction (27.7%). Visceral disorders encompassed lymphedema (86.2%), hypothyroidism (26.2%), and baroreceptor failure (19.2%). Additionally, oncologic complications, including recurrence (18.5%), metastasis (5.4%), and secondary malignancies (8.5%) were observed. Pain (74.6%) and fatigue (31.5%) were reported as major function-limiting impairments. Most survivors (96.9%) were referred to therapy including physical therapy (85.4%), occupational therapy (13.1%), speech-language pathology (84.6%), and lymphedema therapy (72.3%). Most (85.4%) required two or more therapy disciplines.</p><p><strong>Conclusion: </strong>Survivors of HNC accessing cancer rehabilitation services commonly present with diverse, complex, and interrelated neuromuscular, musculoskeletal, visceral, and oncologic late effects that can severely affect function and quality of life. Comprehensive rehabilitation should include evaluation and management of these complex and interrelated late effects by a rehabilitation team that includes cancer rehabilitation physicians, physical therapists, occupational therapists, lymphedema therapists, and speech-language pathologists, among others.</p>","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":"654-662"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12159966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143503550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Functional independence trajectories over 5 years in older veterans with traumatic brain injury: A model systems study.","authors":"Mia E Dini, Rachel E Wallace, Daniel W Klyce, Carmen M Tyler, Michael Vriesman, Shannon B Juengst, Victoria Liou-Johnson, Kelli W Gary, Kristen Dams-O'Connor, Raj G Kumar, Umesh M Venkatesan, Kritzia Merced, Paul B Perrin","doi":"10.1002/pmrj.13312","DOIUrl":"10.1002/pmrj.13312","url":null,"abstract":"<p><strong>Background: </strong>Research on older adults who sustain a traumatic brain injury (TBI) has predominantly been on civilian, nonveteran populations. Military populations experience higher rates of TBI and often experience the additive effects of TBI and other comorbid disorders, including posttraumatic stress disorder and/or substance use that may increase disability over time.</p><p><strong>Objective: </strong>To investigate predictors of functional independence trajectories over the 5 years after TBI in veterans 55 years or older at injury.</p><p><strong>Setting: </strong>Five Veterans Affairs (VA) polytrauma rehabilitation center (PRC) inpatient rehabilitation programs.</p><p><strong>Participants: </strong>Veterans who experienced their TBI at 55 years or older and had completed one or more Functional Independence Measure (FIM) Motor and Cognitive measure at 1, 2, or 5 years after TBI (n = 184) from the VA TBI Model Systems national database.</p><p><strong>Design: </strong>Retrospective analysis of observational data using hierarchical linear models.</p><p><strong>Main measures: </strong>FIM Motor and Cognitive scores at 1, 2, and 5 years after TBI.</p><p><strong>Results: </strong>Motor and cognitive functioning decreased over time. Lower FIM Motor trajectories occurred in participants who had pre-TBI functional limitations in going out of the home and with longer posttraumatic amnesia (PTA). FIM Motor scores decreased over time, and the decrease was steeper for those with a moderate or severe injury. Lower FIM Cognitive trajectories occurred in participants who had problematic substance use at baseline and among those with longer PTA. FIM Cognitive scores decreased at a steeper rate for participants with greater injury severity.</p><p><strong>Conclusions: </strong>Similar to previously published studies in civilian populations, older veterans with TBI may be at risk for functional and cognitive decline. This study's findings increase the field's understanding of functional trajectories after TBI in older adults and may help identifty those who are at risk for lower functional outcomes.</p>","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":"628-637"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12159968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143047632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and treatment outcomes of persistent postural-perceptual dizziness after traumatic brain injury.","authors":"Brandon Johnson, Nathaniel Johnson, Jeffrey Staab, Dmitry Esterov","doi":"10.1002/pmrj.13339","DOIUrl":"10.1002/pmrj.13339","url":null,"abstract":"<p><strong>Background: </strong>Persistent postural-perceptual dizziness (PPPD) is a chronic functional vestibular disorder that is a potential sequela of traumatic brain injury (TBI). Currently, little is known about how patients with TBI associated PPPD respond to typical PPPD treatment modalities.</p><p><strong>Objective: </strong>To investigate the prevalence of TBI as a precipitant for PPPD and assess outcomes of usual treatment.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Electronic medical records from a tertiary care center.</p><p><strong>Participants: </strong>Patients ≥18 years of age diagnosed with PPPD secondary to TBI between January 2015 and December 2022 who underwent 6 months of treatment with at least one return clinic visit.</p><p><strong>Interventions: </strong>Not applicable.</p><p><strong>Main outcome measure(s): </strong>Patients' best clinical global impression-improvement scale (CGI-I) score following 6 months of treatment were collected and then compared with previously published literature, with CGI-I scores of 1 or 2 (indicating the patient was \"very much\" or \"much\" improved, respectively) considered treatment responders.</p><p><strong>Results: </strong>In total, 134 (8.9%) of 1503 patients had a TBI as the triggering event for PPPD. The mean age of this cohort was 47.6 years with most of these cases occurring after a mild TBI (85.8%). The proportion of females with post-TBI PPPD (58.2%) was significantly lower than the proportion with PPPD due to all causes (p < .037). The most common treatment prescribed was vestibular therapy (82.2%), and 53.3% of patients were considered treatment responders after 6 months. Patients with TBI-induced PPPD had a significantly worse mean CGI-I score (2.49 ± 1.1) when compared to prior literature (1.71 ± 0.83) (p < .001).</p><p><strong>Conclusions: </strong>This study found a 9% prevalence of PPPD following TBI in the largest cohort studied to date. Patients who developed PPPD following TBI did not respond as well to standard treatments as patients with other causes of the disorder, and thus may require closer clinical follow-up to assess treatment efficacy.</p>","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":"621-627"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143415036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preoperative muscle weakness is a risk factor for persistent pain 1 year after hip arthroscopy for femoroacetabular impingement syndrome.","authors":"Yuta Nanri, Kohei Nozaki, Takuya Maeda, Hiroyoshi Masuma, Manami Nihei, Takako Uchiya, Masashi Kawabata, Kensuke Fukushima, Michinari Fukuda","doi":"10.1002/pmrj.13352","DOIUrl":"10.1002/pmrj.13352","url":null,"abstract":"<p><strong>Background: </strong>Femoroacetabular impingement syndrome (FAIS) is a common condition causing hip and groin pain. Hip arthroscopy has been established as a viable treatment option when nonoperative management fails to relieve symptoms of FAIS. Despite the numerous positive hip arthroscopy outcomes for FAIS, some individuals experience persistent postoperative pain. Preoperative muscle strength may be associated with persistent pain and function after arthroscopy in patients with FAIS; however, further investigation is necessary to confirm this theory.</p><p><strong>Objective: </strong>To determine the effect of preoperative muscle strength on persistent pain after arthroscopy in patients with FAIS.</p><p><strong>Design: </strong>Retrospective single-institution cohort study.</p><p><strong>Setting: </strong>Tertiary care university hospital in Japan.</p><p><strong>Participants: </strong>Seventy-eight patients who underwent hip arthroscopy for FAIS between December 2015 and September 2021.</p><p><strong>Methods: </strong>Data were collected on patient demographics, preoperative hip abductor and quadriceps strength, preoperative and postoperative visual analog scale (VAS) for pain, and postoperative patient-reported outcomes (PRO). Hip abductor and quadriceps strength were assessed only on the affected side using a hand-held dynamometer. The VAS uses a 100 mm horizontal line to assess pain intensity, with higher values indicating greater pain. PRO was assessed using the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JHEQ) score.</p><p><strong>Interventions: </strong>Not applicable.</p><p><strong>Main outcome measure: </strong>VAS score for pain 1 year postoperatively.</p><p><strong>Results: </strong>Of the 78 patients, 16 (20.5%) had persistent pain (VAS ≥30) 1 year postoperatively. Low preoperative hip abductor and quadriceps strength were associated with persistent pain after arthroscopy even after adjusting for age, gender, and preoperative VAS score (p = .021 and p = .030, respectively). Low preoperative hip abductor and quadriceps strength were associated with lower JHEQ scores 1 year postoperatively even after adjustments (p = .020 and p = .001, respectively).</p><p><strong>Conclusions: </strong>In these patients, low preoperative muscle strength compared with normal muscle strength was a risk factor for persistent pain and poor PRO scores 1 year postoperatively.</p>","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":"612-620"},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143573656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cooled radiofrequency ablation for the treatment of refractory postamputation neuroma-associated pain: A prospective pilot study.","authors":"Cole W Cheney, Kyle Mele, Richard Kendall, Colby Hansen, Beau P Sperry, Amanda N Cooper, Taylor Burnham, Aaron Conger, Zachary L McCormick","doi":"10.1002/pmrj.13412","DOIUrl":"https://doi.org/10.1002/pmrj.13412","url":null,"abstract":"<p><strong>Background: </strong>Radiofrequency ablation (RFA) of neuromas has emerged as a potential treatment option for refractory neuroma-associated postamputation pain (PAP).</p><p><strong>Objective: </strong>To evaluate the feasibility of using internally cooled radiofrequency ablation (C-RFA) for treating neuroma-associated PAP.</p><p><strong>Design: </strong>Prospective single-arm pilot study.</p><p><strong>Setting: </strong>Tertiary academic medical center.</p><p><strong>Participants: </strong>Eight participants with neuroma-associated PAP (mean age 56.5 [interquartile range, 50.5-68.5] years; mean body mass index 30.2 [interquartile range, 26.3-34.8] kg/m²).</p><p><strong>Intervention: </strong>Participants were recruited and treated with C-RFA between 2019 and 2023.</p><p><strong>Main outcome measures: </strong>Pain and functional outcomes were assessed at 1, 3, 6, and 12 months after C-RFA using Numeric Rating Scale (NRS), Groningen Activity Restriction Scale (GARS), Patient Global Impression of Change (PGIC), and Medication Quantification Scale III (MQS-III). Responder definitions for each outcome measure were ≥50% NRS reduction, ≥30% GARS improvement, ≥6 on PGIC, and ≥6.8-point MQS-III reduction.</p><p><strong>Results: </strong>NRS responder rates at 1, 3, 6, and 12 months were 25.0% (95% CI, 7.0%-59.1%), 50.0% (95% CI, 21.5%-78.5%), 37.5% (95% CI, 13.7%-69.4%), and 50.0% (95% CI, 21.5%-78.5%), respectively. Responder rates for GARS were 25.0% (95% CI, 7.1%-59.1%) at 1 month and 12.5% (95% CI, 2.2%-47.1%) at 3, 6, and 12 months. The proportion of PGIC responders was 37.5% (95% CI, 13.7%-69.4%) at 1 and 3 months and 12.5% (95% CI, 2.2%-47.1%) at 6 and 12 months. MQS-III responder rates were 25.0% (95% CI, 7.1%-59.1%) at 1 month, 12.5% (95% CI, 2.2%-47.1%) at 3 months, and 37.5% (95% CI, 13.7%-69.4%) at 6 and 12 months. There were no complications associated with the C-RFA procedure.</p><p><strong>Conclusions: </strong>These findings indicate the feasibility of neuroma C-RFA as a treatment for refractory neuroma-associated PAP but also suggest that further patient selection and C-RFA technique optimization are warranted before investigating this treatment paradigm in a larger prospective study.</p>","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144187819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of \"3D printing in medicine\" course leads to creation of a functional prosthetic for underserved patient.","authors":"John Spencer Laue, Thomas Shevlin, Sarika Mullapudi, Peter Anthony, Conley Carr","doi":"10.1002/pmrj.13427","DOIUrl":"https://doi.org/10.1002/pmrj.13427","url":null,"abstract":"","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144187820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes in transhumeral upper limb amputation with osseointegration and targeted muscle reinnervation: A preliminary observational cohort study.","authors":"Joseph Webster, Jeffrey Heckman, Matthew Borgia, Jemy Delikat, Linda Resnik","doi":"10.1002/pmrj.13407","DOIUrl":"https://doi.org/10.1002/pmrj.13407","url":null,"abstract":"<p><strong>Background: </strong>Little is known about outcomes associated with the combination of osseointegration (OI) and targeted muscle reinnervation (TMR) in upper limb amputation (ULA).</p><p><strong>Objectives: </strong>To describe functional outcomes of three cases with OI and TMR who used myoelectric prostheses and compare outcomes to matched control groups.</p><p><strong>Design: </strong>An observational cohort, quasiexperimental design with nonequivalent control groups was used. Wilcoxon Mann-Whitney and Fisher's exact tests compared outcomes between OI cases, control group 1 (six myoelectric/hybrid users without TMR or OI), and control group 2 (seven myoelectric/hybrid users with TMR but not OI). Hedges' g effect sizes (ES) were calculated.</p><p><strong>Setting: </strong>Community dwelling adults.</p><p><strong>Participants: </strong>U.S. veterans and civilians with transhumeral ULA.</p><p><strong>Interventions: </strong>OI and TMR.</p><p><strong>Main outcome measures: </strong>We employed 11 dexterity measures, 5 functional measures, 5 prosthesis satisfaction measures, 4 quality of life measures, 7 patient experience measures, 4 measures of prosthesis use, and 10 pain measures.</p><p><strong>Results: </strong>Comparison 1: Cases had higher scores than controls on Brief Activity Measure for ULA (ES = 1.59; p = .08), Prosthesis Evaluation Questionnaire Residual Limb Health (ES = 1.54; p = .09), Patient Experience Measure Intuitiveness (2.33; p = .07), and h/d of prosthesis use (ES = 1.40; p = .09). Comparison 2: Cases had better prosthesis satisfaction as measured by the Trinity Amputation and Prosthesis Experience Satisfaction Scale (ES = 2.36; p = .05); Orthotics and Prosthetics User Survey Client Satisfaction with Devices (CSD) 8 (ES = -2.70; p = .08); CSD-W Comfort (ES = 3.51; p = .05); and the CSD-W Appearance (ES = 2.36; p = .09), higher scores of the Upper Extremity Functional Scale for Prosthesis Users One-handed Task scale (ES = 2.27; p = .05); the Modified Prosthesis Evaluation Questionnaire (PEQ) Residual Limb Health scale (ES = 1.95; p = .07); and Patient Experience Measure (PEM) Intuitiveness scales (ES = 2.28; p = .05). Cases had greater prosthesis use, measured by d/wk of wear, d/wk of use, h/d of wear, and h/d of use with ES ranging from 0.93 to 2.03 and p values from .05 to .08 for nonparametric tests.</p><p><strong>Conclusion: </strong>Cases with OI and TMR reported better residual limb health, greater intuitiveness, and more hours of daily prosthesis use than controls. Further study with larger samples is warranted to investigate the additive benefit of both OI and TMR.</p>","PeriodicalId":20354,"journal":{"name":"PM&R","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144174623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}